Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer

Cancer Science

Volumn 102, Issue 11, 2011, Pages 2029-2037

  Kato, Shingo ^a   Kubota, Kensuke ^a   Shimamura, Takeshi ^a   Shinohara, Yoshiyasu ^a   Kobayashi, Noritoshi ^a   Watanabe, Seitaro ^a   Yoneda, Masato ^a   Inamori, Masahiko ^a   Nakamura, Fumio ^a   Ishiguro, Hitoshi ^a,b   Nakaigawa, Noboru ^a   Nagashima, Yoji ^a   Taguri, Masataka ^a   Kubota, Yoshinobu ^a   Goshima, Yoshio ^a   Morita, Satoshi ^a   Endo, Itaru ^a   Maeda, Shin ^a   Nakajima, Atsushi ^a   Nakagama, Hitoshi ^c  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANAGAWA ACADEMY OF SCIENCE AND TECHNOLOGY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD20 ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PLEXIN; PLEXINB1; PROTEIN KINASE B; RAS PROTEIN; SEMAPHORIN; SEMAPHORIN 4D; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER INVASION; CANCER TISSUE; CELL MOTILITY; CELL TYPE; DISTANT METASTASIS; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORPHOGENESIS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR GROWTH;

AGED; ANTIGENS, CD; CARCINOMA, PANCREATIC DUCTAL; CELL MOVEMENT; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; SEMAPHORINS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 80054982469     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02053.x     Document Type: Article

References (25)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Tanaka T, Ikeda M, Okusaka T et al. Prognostic factors in japanese patients with advanced pancreatic cancer treated with single-agent gemcitabine as first-line therapy. Jpn J Clin Oncol 2008; 38: 755-61.
3. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004; 363: 1049-57.
4. Pasterkamp RJ, Kolodkin AL. Semaphorin junction: making tracks toward neural connectivity. Curr Opin Neurobiol 2003; 13: 79-89.
5. Kolodkin AL, Matthes DJ, Goodman CS. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 1993; 75: 1389-99.
6. Bismuth G, Boumsell L. Controlling the immune system through semaphorins. Sci STKE 2002; 128: re4.
7. Kikutani H, Kumanogoh A. Semaphorins in interactions between T cells and antigen presenting cells. Nat Rev Immunol 2003; 3: 159-67.
8. Giordano S, Corso S, Conrotto P et al. The semaphorin 4D receptor controls invasive growth by coupling with Met. Nat Cell Biol 2002; 4: 720-4.
9. Tse C, Xiang RH, Bracht T, Naylor SL. Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. Cancer Res 2002; 62: 542-6.
10. Christensen CR, Klingelhöfer J, Tarabykina S, Hulgaard EF, Kramerov D, Lukanidin E. Transcription of a novel mouse semaphoring gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines. Cancer Res 1998; 58: 1238-44.
11. Boumsell L, Schmid M, Dastot H, Gouttefangeas C, Mathieu-Mahul D, Bensussan A. In vitro differentiation from a pluripotent human CD4+CD8+ thymic cloned cell into four phenotypically distinct subsets. J Immunol 1990; 145: 2797-802.
12. Bougeret C, Mansur IG, Dastot H et al. Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J Immunol 1992; 148: 318-23.
13. Hall KT, Boumsell L, Schultze JL et al. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci USA 1996; 93: 11780-5.
14. Kumanogoh A, Watanabe C, Lee I et al. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity 2000; 13: 621-31.
15. Tamagnone L, Artigiani S, Chen H et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI anchored semaphorins in vertebrates. Cell 1999; 99: 71-80.
16. Gentile A, Trusolino L, Comoglio PM. The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev 2008; 27: 85-94.
17. Basile JR, Barac A, Zhu T, Guan KL, Gutkind JS. Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res 2004; 64: 5212-24.
18. Basile JR, Gavard J, Gutkind JS. Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility. J Biol Chem 2007; 282: 34888-95.
19. Sierra JR, Corso S, Caione L et al. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J Exp Med 2008; 205: 1673-85.
20. Hermanek P, Hutter RVP, Sobin LH, Wagner G, Wittekind CH. TNM Atlas, 4th edn. Berlin: SpringerVerlag, 1997; 144-53.
21. Japan Pancreas Society. Classification of Pancreatic Carcinoma, (English Edition). Tokyo: Kanehara, 1998; 39.
22. Kloppel G, Hruban RH, Longnecker DS, Adler G, Kern SE, Partanen TJ. Ductal adenocarcinoma of the pancreas. In: Hamilton SR, Aaltonen LA, eds. Pathology and Genetics. Tumours of the Digestive System. WHO classification of tumours. Lyon: IARC Press, 2000; 220-30.
23. Basile JR, Afkhami T, Gutkind JS. Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Mol Cell Biol 2005; 25: 6889-98.
24. Tonini G, Pantano F, Vincenzi B, Gabbrielli A, Coppola R, Santini D. Molecular prognostic factors in patients with pancreatic cancer. Expert Opin Ther Targets 2007; 11: 1553-69.
25. Ch'ng E, Tomita Y, Zhang B et al. Prognostic significance of CD100 expression in soft tissue sarcoma. Cancer 2007; 110: 164-72.